Vimarsana
Biggest News Aggregation in the World

Page 12 - Transplant Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Transplant Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Transplant Program Today - Breaking & Trending Today

Could NJ be next for pig-to-human heart transplants? - Vimarsana News

Could NJ be next for pig-to-human heart transplants?

Around 115,000 people across the country are waiting for heart transplants. Almost 4,000 of those are in NJ.

Source: nj1015.com
First-in-Human Trial with CAR Macrophages Shows the Cell Therapy May Be Safe, Feasible for Solid Tumors - Vimarsana News

First-in-Human Trial with CAR Macrophages Shows the Cell Therapy May Be Safe, Feasible for Solid Tumors

Preliminary findings from Penn Medicine in an ongoing first-in-human clinical trial examining the safety, tolerability and feasibility of chimeric antigen recep

Phase 1 clinical trial shows the safety, feasibility of CAR-M cell therapy for solid tumors - Vimarsana News

Phase 1 clinical trial shows the safety, feasibility of CAR-M cell therapy for solid tumors

Preliminary findings from Penn Medicine in an ongoing first-in-human clinical trial examining the safety, tolerability and feasibility of chimeric antigen receptor macrophage (CAR-M) has helped to establish the viability of this innovative immunotherapy, which advances the trailblazing scientific discovery of CAR T cell therapy- also pioneered at Penn- for solid cancer tumors and offers a promising new strategy in the fight against cancer.

New Resource from NCCN Shares Evidence-Based Approaches to Recognize and Manage Graft-Versus-Host Disease after Stem Cell Transplantation - Vimarsana News

New Resource from NCCN Shares Evidence-Based Approaches to Recognize and Manage Graft-Versus-Host Disease after Stem Cell Transplantation

/PRNewswire/ -- The National Comprehensive Cancer Network (NCCN®) today announced the publication of new NCCN Guidelines for Patients®: Graft-Versus-Host...

NCCN publishes new guidelines for managing patients with Graft-Versus-Host Disease - Vimarsana News

NCCN publishes new guidelines for managing patients with Graft-Versus-Host Disease

The National Comprehensive Cancer Network today announced the publication of new NCCN Guidelines for Patients: Graft-Versus-Host Disease (GVHD).